As a USP1 inhibitor, ML323 reduces macrophage infiltration, regulates CD4+ T cell differentiation, and inhibits Th17 cell development, maintaining immune balance and exerting anti-tumor effects (52–54). Here, CD4 is linked to neoplasm.